Livestock disease risk at livestock and aquaculture operators and the companies’ own farms
First written in FY2016. 19 of 36 entries say "Restated". Latest entry: 2026-11-10.
Nichiwa Sangyo moved to the "Worse" side of this theme in 2026, 7 years after the typical company in this theme (2019).
The whole theme swung hardest in 2026: 6 of 6 companies on the "Worse" side.
1 other company's latest entry also says "Materialised".
- FY2026MaterialisedAnnual report
「Egg supplies have declined due to recurring outbreaks of avian influenza, and prices have remained high throughout the year.」
The company states that recurring outbreaks of avian influenza actually appeared in market conditions as lower supplies and high egg prices. - FY2026-H1MitigatedAnnual report
「Although egg prices have been falling since July, they have remained higher than in the same period of the previous year due to the impact of last year’s avian influenza outbreak.」
The company states that the impact of last year’s avian influenza outbreak on supply continues, while egg prices have been falling since July. - FY2025MaterialisedAnnual report
「Egg prices fell as production recovered from the decline caused by avian influenza, but remained high again from October onward due to the impact of new avian influenza outbreaks.」
The company states that the recurrence of avian influenza actually affected egg production volumes and prices from October onward. - FY2025-H1Rebound in egg prices following the impact of avian influenzaAnnual report
「Egg prices fell as production recovered from the decline caused by avian influenza, but have been trending upward again due to production adjustments and other factors.」
The company states that prices fell as production recovered from the decline caused by avian influenza, then began trending upward again due to production adjustments and other factors. - FY2024MitigatedAnnual report
「Egg prices surged following the production decline caused by avian influenza in the previous fiscal year, but fell as production recovered.」
The company states that although the impact of avian influenza on egg supplies remains, prices fell as production recovered. - FY2024-Q3MitigatedAnnual report
「Egg prices remained high, continuing the trend from the previous fiscal year, due to the impact of avian influenza, but softened toward year-end as production recovered.」
The company states that the impact of avian influenza on egg prices continued, but that prices softened toward year-end as production recovered. - FY2024-Q2MitigatedAnnual report
「Although egg prices are recovering from the production decline caused by avian influenza in the previous fiscal year, they remain high.」
The company states that egg prices are recovering from the production decline caused by avian influenza in the previous fiscal year, while prices remain high. - FY2024-Q1MaterialisedAnnual report
「Egg prices remained high, continuing the trend from the previous fiscal year, due to the impact of avian influenza.」
The company states that the impact of avian influenza actually appeared in market conditions as egg prices remained high for a second consecutive fiscal year. - FY2023MaterialisedAnnual report
「Egg prices surged from the end of the year as production declined due to the impact of avian influenza. Pork prices exceeded the previous year’s level as production declined under the impact of swine fever, while demand remained firm because of higher import prices.」
The company states that the impact of avian influenza and swine fever actually appeared in egg and pork production volumes and market prices. - FY2023-Q3MaterialisedAnnual report
「In livestock product markets, egg production declined due to the impact of avian influenza, and prices rose sharply.」
The company states that the impact of avian influenza actually appeared in market conditions as lower egg production and higher prices. - FY2023-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that management recognizes could materially affect the financial position, operating results and cash flows of the consolidated companies, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company states that there have been no material changes in its key risks, including the risk of livestock diseases among livestock producers and at its own farms. - FY2022RestatedAnnual report
「The Group sells compound feed to livestock and aquaculture operators. If an infectious disease occurs among these operators, it could affect the manufacture and sale of compound feed and, consequently, the Group’s operating results and financial position.」
The company continues to disclose livestock disease risks at customers’ farms and its own and consolidated subsidiaries’ farms. - FY2022-Q2RestatedAnnual report
「Egg prices had risen because of supply shortages caused by avian influenza outbreaks in the previous year, but signs of a gradual recovery emerged and prices have been falling since around August.」
The company states that the impact of supply shortages caused by avian influenza outbreaks in the previous year continued into the current quarter, while also noting signs of recovery in egg prices. - FY2022-Q1MaterialisedAnnual report
「In livestock product markets, egg prices have risen because supply shortages caused by last year’s outbreaks of avian influenza have continued. Chicken prices remained soft owing to increased import volumes.」
The company states that supply shortages caused by avian influenza outbreaks in the previous year continued into the current quarter and actually affected egg prices. - FY2021-Q3MaterialisedAnnual report
「Egg prices had been falling due to declining demand, but rose following outbreaks of avian influenza. Chicken prices have remained firm, owing to the impact of avian influenza in addition to the decline in import volumes.」
The company states that outbreaks of avian influenza actually affected egg and chicken prices. However, it does not mention any outbreaks at its own farms. - FY2021-Q2RestatedAnnual report
「During the six months ended the second quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no new outbreaks or material changes in business and other risks, including the risk of livestock diseases among livestock producers and at its own farms. - FY2021-Q1RestatedAnnual report
「During the three months ended the first quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no new outbreaks or material changes in the risk of livestock diseases among livestock producers or at its own farms. - FY2020RestatedAnnual report
「Although each of the Group’s livestock rearing facilities implements hygiene measures such as disinfection and works to detect abnormal livestock at an early stage, an outbreak of a livestock infectious disease could affect the Group’s operating results and financial position through the mass disposal of products, the suspension of livestock rearing until the situation is brought under control, and other measures.」
The company continues to disclose livestock disease risks at customers’ farms and its own and consolidated subsidiaries’ farms. - FY2020-Q3RestatedAnnual report
「During the cumulative consolidated third quarter, there were no new business or other risks, nor any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company states that there have been no new outbreaks or material changes in the risk of livestock diseases among livestock producers or at its own farms. - FY2020-Q2RestatedAnnual report
「During the six months ended the second quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no new outbreaks or material changes in the risk of livestock diseases among livestock producers or at its own farms. - FY2019RestatedAnnual report
「Although each of the Group’s livestock rearing facilities implements hygiene measures such as disinfection and works to detect abnormal livestock at an early stage, an outbreak of a livestock infectious disease could affect the Group’s operating results and financial position through the mass disposal of products, the suspension of livestock rearing until the situation is brought under control, and other measures.」
The company continues to disclose livestock disease risks at customers’ farms and its own and consolidated subsidiaries’ farms. - FY2019-Q3RestatedAnnual report
「During the cumulative consolidated third quarter, there were no new business or other risks, nor any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company states that there have been no new outbreaks or material changes in the risk of livestock diseases among livestock producers or at its own farms. - FY2019-Q2RestatedAnnual report
「During the six months ended the second quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no new outbreaks or material changes in the risk of livestock diseases among livestock producers or at its own farms. - FY2018RestatedAnnual report
「The Group produces eggs and pork at its own farms and those of its consolidated subsidiaries. Although each rearing facility implements hygiene measures such as disinfection and works to detect abnormal livestock at an early stage, an outbreak of a livestock infectious disease could affect the Group’s operating results and financial position through the mass disposal of products, the suspension of livestock rearing until the situation is brought under control, and other measures.」
The company continues to disclose livestock disease risks at customers’ farms and its own and consolidated subsidiaries’ farms. - FY2018-Q3RestatedAnnual report
「During the cumulative consolidated third quarter, there were no new business or other risks, nor any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company states that there have been no new outbreaks or material changes in the risk of livestock diseases among livestock producers or at its own farms. - FY2018-Q2RestatedAnnual report
「During the six months ended the second quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no new outbreaks or material changes in the risk of livestock diseases among livestock producers or at its own farms. - FY2018-Q1RestatedAnnual report
「During the three months ended the first quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no material changes in the risk of livestock diseases among livestock producers or at its own farms. - FY2017RestatedAnnual report
「The Group produces eggs and pork at its own farms and those of its consolidated subsidiaries. Although each rearing facility implements hygiene measures such as disinfection and works to detect abnormal livestock at an early stage, an outbreak of a livestock infectious disease could affect the Group’s operating results and financial position through the mass disposal of products, the suspension of livestock rearing until the situation is brought under control, and other measures.」
The company continues to disclose disease risks at customers’ farms and its own and consolidated subsidiaries’ farms. - FY2017-Q3RestatedAnnual report
「During the nine months ended the third quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no material changes in the risk of livestock diseases among livestock producers or at its own farms. - FY2017-Q2RestatedAnnual report
「During the six months ended the second quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no material changes in the risk of livestock diseases among livestock producers or at its own farms. - FY2017-Q1RestatedAnnual report
「During the three months ended the first quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no material changes in the risk of livestock diseases among livestock producers or at its own farms. - FY2016First statedAnnual report
「If an infectious disease occurs among livestock producers, the manufacture and sale of formula feed may be affected, which could affect the operating results and financial position of the Group.」
The risks include both disease outbreaks at customers and livestock infectious diseases at the company’s own farms and consolidated subsidiaries.